Carle receives cancer center grant
URBANA — The Carle Cancer Center will receive nearly $1 million a year for five years through the National Cancer Institute to help support its research and clinical trials.
Carle was selected for one of the 53 five-year grants being awarded by the NCI’s new Community Oncology Research Program, a new network of cancer care providers, investigators, academic institutions and other organizations. This network replaces two previous NCI programs, the Community Clinical Oncology Program and the Community Cancer Centers Program.
The new program is being funded at $93 million a year for the five years, according to the NCI.
Carle was one of 34 cancer centers selected to receive community-based site funding. There are also 12 other grants going to centers predominately in minority or under-served communities and seven going to research bases, according to the NCI.
Community-based sites accrue patient to participate in clinical trials conducted by NCORP research bases, the NCI National Clinical trials Network, treatment and imaging trials, quality of life studies and cancer care delivery research involving patients, practitioners, and/or health care organizations, according to the NCI.
Carle officials said the grant funding will cover operational, enrollment and regulatory compliance to allow Carle patients access to more cancer research studies.
“This grant is a stamp of approval from the National Cancer Institute when it comes to Carle’s cancer research program,” Dr. Kendrith Rowland, an oncologist and principal investigator at the Carle Cancer Center, said in a statement. "We are proud of the years of research to help our patients and others and are
pleased to be among the elite cancer research facilities in the nation.”